Press Releases from DelveInsight Business Research (6359 total)
Panic Disorder Market Outlook Through 2032: Growing Worldwide Disease Burden and …
DelveInsight's latest report, "Panic Disorder Market Insights, Epidemiology, and Market Forecast-2032," presents an in-depth analysis of the Panic Disorder market, encompassing past performance, present dynamics,…
Cancer Vaccines Clinical Trial Outlook: 250+ Companies, 300+ Assets, and the Fut …
DelveInsight has released its newest strategic intelligence publication, "Cancer Vaccines - Competitive Landscape," providing an in-depth assessment of the global cancer vaccines ecosystem. The report…
Clostridium Difficile Infections Clinical Trials Outlook: 20+ Companies, 22+ Pip …
According to DelveInsight's evaluation, the global Clostridium difficile infections (Clostridium difficile infections) pipeline features more than 20 active pharmaceutical and biotechnology companies collectively advancing over…
GLP-1 Agonists Market 2034: 7MM Insights, 6+ Active Companies, 5 Key Pipeline Dr …
DelveInsight's latest GLP-1 Agonists Market Insights Report provides a in-depth and forward-looking analysis of one of the most dynamic therapeutic classes shaping the future of…
WEGOVY (Semaglutide) Market Size, Forecast, and Drug Insight Report Highlighting …
DelveInsight, a leading life science market research and business consulting firm, has announced the release of its latest in-depth report titled "WEGOVY (Semaglutide), Market Size,…
HR Positive/ HER2 Negative Breast Cancer Pipeline 2025: Key Developments, Emergi …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, HR Positive/ HER2 Negative Breast Cancer pipeline constitutes 50+ key companies continuously working towards…
Ulcerated Necrobiosis Lipoidica Market: Fast-Growing Therapeutics Outlook by 203 …
DelveInsight's "Ulcerated Necrobiosis Lipoidica Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Ulcerated Necrobiosis Lipoidica, historical and forecasted epidemiology as…
Trigeminal Neuralgia Market: Rapid Growth & Investment Outlook to 2034 - DelveIn …
DelveInsight's "Trigeminal Neuralgia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Trigeminal Neuralgia, historical and forecasted epidemiology as well as…
Anti-CD19 Antibody Pipeline 2025: FDA Approvals and Clinical Trials Landscape wi …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Anti-CD19 Antibody pipeline constitutes 12+ key companies continuously working towards developing 12+ Anti-CD19 Antibody…
Kidney Transplant Rejection Pipeline 2025: Therapies, MOA Insights, and Key Clin …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Kidney Transplant Rejection pipeline constitutes 6+ key companies continuously working towards developing 8+ Kidney…
Catheter Related Bloodstream Infections Market Growth Projections 2024-2034: Del …
DelveInsight's "Catheter Related Bloodstream Infections Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Catheter Related Bloodstream Infections, historical and forecasted…
Cutaneous Lupus Erythematosus Market to Expand Significantly by 2034, States Del …
DelveInsight's "Cutaneous Lupus Erythematosus Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Cutaneous Lupus Erythematosus, historical and forecasted epidemiology as…
Fibrodysplasia Ossificans Progressiva Pipeline 2025: Latest FDA Approvals, Clini …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Fibrodysplasia Ossificans Progressiva pipeline constitutes 5+ key companies continuously working towards developing 7+ Fibrodysplasia…
Pancreatic Ductal Adenocarcinoma Pipeline 2025: Key Companies, MOA, ROA, and Cli …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Pancreatic Ductal Adenocarcinoma pipeline constitutes 80+ key companies continuously working towards developing 80+ Pancreatic…
Global Structural Heart Devices Market to grow at a CAGR of 10.08% to reach USD …
According to DelveInsight's analysis, The Structural Heart Devices market is the growing prevalence of cardiovascular and valvular diseases, such as aortic stenosis, mitral regurgitation, and…
Short Bowel Syndrome Market Trends Point to Steady Growth Ahead by 2034, DelveIn …
DelveInsight's "Short Bowel Syndrome Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Short Bowel Syndrome, historical and forecasted epidemiology as…
Sensorineural Hearing Loss Market Expected to Gain Momentum Through 2034, Accord …
The Sensorineural Hearing Loss market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage…
Sarcoidosis Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Sarcoidosis pipeline constitutes 15+ key companies continuously working towards developing 15+ Sarcoidosis treatment therapies,…
Retinitis Pigmentosa Market to Witness Promising Upswing by 2034, DelveInsight F …
The Retinitis Pigmentosa market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Retinitis…
Aspergillosis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsigh …
The Aspergillosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Aspergillosis pipeline…
High-grade Glioma Market Insights Highlight Expanding Outlook Till 2034, DelveIn …
DelveInsight's "High-grade Glioma Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the High-grade Glioma, historical and forecasted epidemiology as well as…
Dyslipidemia Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Dyslipidemia pipeline constitutes key companies continuously working towards developing Dyslipidemia treatment therapies, analysis of…
Friedreich Ataxia Market to Evolve Rapidly Over the Next Decade by 2034, DelveIn …
The Friedreich's Ataxia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Friedreich's…
Retinal Vein Occlusion Pipeline 2025: Therapies, MOA Insights, and Key Clinical …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Retinal Vein Occlusion pipeline constitutes 15+ key companies continuously working towards developing 15+ Retinal…
Heart failure with Reduced Ejection Fraction Market to Witness Promising Upswing …
The Heart failure with Reduced Ejection Fraction market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore,…
HER2-Negative Breast Cancer Pipeline and Clinical Trial Analysis: 70+ Players, 7 …
DelveInsight's "HER2-Negative Breast Cancer Pipeline Insight" report delivers an extensive analysis of more than 70 companies and 75 pipeline candidates shaping the HER2-negative breast cancer…
Marginal Zone Lymphoma Pipeline and Clinical Trial Analysis: 50+ Players, 50+ As …
DelveInsight's "Marginal Zone Lymphoma Pipeline Insight" report delivers an in-depth analysis of more than 50 companies and 50+ investigational drugs shaping the Marginal Zone Lymphoma…
Non-Muscle Invasive Bladder Cancer Pipeline and Clinical Trial Analysis: 20+ Pla …
DelveInsight's "Non-Muscle Invasive Bladder Cancer Pipeline Insight" report delivers an in-depth analysis of more than 20 companies and over 22 investigational therapies shaping the NMIBC…
Myocardial Infarction Market to Evolve Rapidly Over the Next Decade by 2034, Del …
DelveInsight's "Myocardial Infarction Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myocardial Infarction, historical and forecasted epidemiology as well as…
Fibromyalgia Market Insights Highlight Expanding Outlook Till 2034, DelveInsight …
DelveInsight's "Fibromyalgia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Fibromyalgia, historical and forecasted epidemiology as well as the Fibromyalgia…
Focal Segmental Glomerulosclerosis Market to Experience Notable Growth in Foreca …
DelveInsight's "Focal Segmental Glomerulosclerosis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Focal Segmental Glomerulosclerosis, historical and forecasted epidemiology as…
Diabetic Kidney Disease Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinica …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Diabetic Kidney Disease pipeline constitutes key companies continuously working towards developing Diabetic Kidney Disease…
Congestive Heart Failure Market Dynamics Indicate Upward Trajectory Through 2034 …
DelveInsight's "Congestive Heart Failure Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Congestive Heart Failure, historical and forecasted epidemiology as…
Critical Limb Ischemia Market Expected to Gain Momentum Through 2034, According …
DelveInsight's "Critical Limb Ischemia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Critical Limb Ischemia, historical and forecasted epidemiology as…
Crohn's Disease Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Crohn's Disease pipeline constitutes 40+ key companies continuously working towards developing 50+ Crohn's Disease…
Coronary Microvascular Dysfunction Market Trends Point to Steady Growth Ahead by …
The Coronary Microvascular Dysfunction market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage…
Fuchs Endothelial Corneal Dystrophy Market Dynamics Indicate Upward Trajectory T …
DelveInsight's "Fuchs Endothelial Corneal Dystrophy Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Fuchs Endothelial Corneal Dystrophy, historical and forecasted…
Desmoid Tumors Market to Experience Notable Growth in Forecast Span by 2034, Del …
DelveInsight's "Desmoid Tumors Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Desmoid Tumors, historical and forecasted epidemiology as well as…
Treg Cell-Based Therapies Clinical Trial Landscape Expands With 55+ Emerging The …
The "Treg Cell-Based Therapies Pipeline Insight" report delivers a detailed assessment of therapeutic programs spanning the entire development continuum, from early discovery and preclinical research…
Open-Angle Glaucoma Clinical Research Expands With 20+ Emerging Therapies, Repor …
Several companies are actively advancing innovation in the Open-Angle Glaucoma market, including Nicox Ophthalmics, Betaliq, Inc., Qlaris Bio, Aerpio Pharmaceuticals, Theratocular Biotek, PolyActiva Pty Ltd.,…
Chronic Heart Failure market size in 7MM was nearly USD 5.6 billion in 2023, ana …
Key Chronic Heart Failure Market Players include Novartis, Boehringer Ingelheim, Eli Lilly and Company, Bayer, Cytokinetics, BioCardia, Novo Nordisk, Mesoblast, among others.
DelveInsight's latest publication, "Congestive…
Global Spasticity Therapeutics Poised for Major Evolution: DelveInsight Reveals …
DelveInsight's newly published report, "Spasticity Pipeline Insight" delivers a comprehensive analysis of over 10 pharmaceutical and biotech companies actively developing more than 12 potential therapies…
Global Advanced Melanoma Pipeline Gains Momentum With Over 60 Novel Therapies, A …
DelveInsight's latest publication, "Advanced Melanoma Pipeline Insight," provides a comprehensive assessment of the evolving Advanced Melanoma R&D landscape, covering more than 55 pharmaceutical and biotechnology…
Geographic Atrophy Clinical Trial Analysis: 25+ Drugs, 23+ Companies Redefining …
DelveInsight's newly released report, "Geographic Atrophy Pipeline Insight" offers a comprehensive analysis of the evolving Geographic Atrophy (GA) therapeutic landscape, covering 23+ biopharmaceutical companies and…
Interstitial Lung Disease Clinical Trial Analysis: 120+ Drugs and 120+ Companies …
DelveInsight, a prominent market intelligence and consulting organization in the life sciences domain, has announced the launch of its newest report titled "Interstitial Lung Disease…
Global Vein Illumination Devices Market Forecast to Reach USD 152.83 Million by …
DelveInsight's latest publication, "Vein Illumination Devices Market Insights, Competitive Landscape and Market Forecast-2032," offers a comprehensive analysis of existing and future market dynamics. The report…
Liver Cancer Clinical Trial Analysis: 75+ Drugs, 70+ Companies Redefining the Fu …
DelveInsight's "Liver Cancer Pipeline Insights 2025" delivers an in-depth overview of the liver cancer pipeline ecosystem, profiling more than 70 companies and 75+ therapeutic candidates…
Limbal Stem Cell Deficiency Market to Surpass USD 2.6 Billion by 2034, Driven by …
In 2023, the Limbal Stem Cell Deficiency (LSCD) market was dominated by the United States, generating nearly USD 1.5 billion in revenue, while Spain represented…
SSc-ILD Market Set to Cross USD 750 Million by 2034, Driven by 10+ Emerging Ther …
The major players operating in the Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market include Roche, Prometheus Biosciences, Inc., Merck, GlaxoSmithKline, Genentech, Inc., Acceleron, Boehringer Ingelheim,…
Developmental and Epileptic Encephalopathy Treatment Market Poised for Accelerat …
The Developmental and Epileptic Encephalopathy (DEE) treatment market across the seven major markets (7MM) was valued at nearly USD 2.1 billion in 2023 and is…
Go To Page: 1 2 3 4 5 6 7 8 9 10 101 102 103 104 105 106 107 108 109 110
